돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2070215생성일: 2026년 10월 27일

Paclitaxel → Taxane

https://huagongshe.com/reaction/2070215

반응식

참여 물질

역할이름HCID투입량
반응물PaclitaxelHCID 36314—
반응물DocetaxelHCID 148124—
반응물CanadensolHCID 9832370—
생성물TaxaneHCID 9548828—
생성물PhenylisoserineHCID 18363976—

반응 단계

In brief, the present invention relates to an improved semi-synthetic process to produce a taxane intermediate, which can ultimately be used to produce taxane derivatives, such as paclitaxel, docetaxel and canadensol and its derivatives. In the process of the present invention, the protected taxane intermediate from which the taxane derivative can be derived is produced in a yield of over 65% of a single isomer by direct esterification of a protected taxane of formula (I) with a single isomeric open chain phenyl isoserine side chain. By using a single isomeric phenyl isoserine side chain, a single isomeric taxane intermediate is obtained at a yield of over 65%. This is substantially greater than the 40% yield of the process advanced by Denis et al in U.S. Pat. No. 4,924,011. In addition, by using the same hydroxyl protecting group to protect both the C-7 position and the 2′-position on the phenylisoserine side chain, simplifies and reduces the reaction route. These are all features which would be recognised as being advantageous in industrial scale up of the present process.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08299279B2
출처 데이터셋uspto-grants-2012_10
ORD IDord-7cce0a54458f4d0e8b987c0a9612f6ec
출처 메모uspto-grants-2012_10